Patents by Inventor Olga Zolotareva

Olga Zolotareva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines
    Patent number: 11904002
    Abstract: Methods described herein relate to constructing therapeutic fusion-specific vaccine libraries, selecting a therapeutic fusion-specific vaccine for a cancer patient, and/or constructing a de novo therapeutic fusion-specific vaccine for patients having a gene fusion that is absent from a fusion-specific vaccine library.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: February 20, 2024
    Assignee: BostonGene Corporation
    Inventors: Maksym Artomov, Feliks Frenkel, Igor Golubev, Olga Zolotareva
  • CONSTRUCTION AND METHODS OF USE OF A THERAPEUTIC CANCER VACCINE LIBRARY COMPRISING FUSION-SPECIFIC VACCINES
    Publication number: 20200054728
    Abstract: Methods described herein relate to constructing therapeutic fusion-specific vaccine libraries, selecting a therapeutic fusion-specific vaccine for a cancer patient, and/or constructing a de novo therapeutic fusion-specific vaccine for patients having a gene fusion that is absent from a fusion-specific vaccine library.
    Type: Application
    Filed: November 1, 2019
    Publication date: February 20, 2020
    Applicant: BostonGene Corporation
    Inventors: Maksym Artomov, Feliks Frenkel, Igor Golubev, Olga Zolotareva
  • CONSTRUCTION AND METHODS OF USE OF A THERAPEUTIC CANCER VACCINE LIBRARY COMPRISING FUSION-SPECIFIC VACCINES
    Publication number: 20190030147
    Abstract: Methods described herein relate to constructing therapeutic fusion-specific vaccine libraries, selecting a therapeutic fusion-specific vaccine for a cancer patient, and/or constructing a de novo therapeutic fusion-specific vaccine for patients having a gene fusion that is absent from a fusion-specific vaccine library.
    Type: Application
    Filed: August 22, 2018
    Publication date: January 31, 2019
    Inventors: Maksym Artomov, Feliks Frenkel, Igor Golubev, Olga Zolotareva